Corsicana & Co’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54K Buy
+75
New +$2.5K ﹤0.01% 284
2026
Q1
Sell
-75
Closed -$2.34K 282
2025
Q4
$2.34K Hold
75
﹤0.01% 244
2025
Q3
$1.51K Buy
+75
New +$1.32K ﹤0.01% 251
2022
Q3
$1K Hold
100
﹤0.01% 206
2022
Q2
$1K Hold
100
﹤0.01% 209
2022
Q1
$1K Hold
100
﹤0.01% 211
2021
Q4
$1K Hold
100
﹤0.01% 208
2021
Q3
$1K Hold
100
﹤0.01% 209
2021
Q2
$1K Buy
+100
New +$1.06K ﹤0.01% 202

Other funds holding TEVA

Corsicana & Co's TEVA Position: Q2 2026 in Review

Corsicana & Co opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 75 shares worth $2.54K. The stake represents ﹤0.01% of the portfolio and ranks #284 among its holdings. This is a return to the name: Corsicana & Co previously reported a position in TEVA as recently as Q4 2025.

Corsicana & Co first reported a position in TEVA in Q2 2021 and has held it in 9 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Corsicana & Co held 75 shares of Teva Pharmaceutical Industries Limited worth $2.54K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Corsicana & Co position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Corsicana & Co's portfolio in Q2 2026, its #284 holding.
  • Corsicana & Co first reported a position in Teva Pharmaceutical Industries Limited in Q2 2021 and has held it in 9 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.